Teva in talks to buy Allergan big generic-drug unit: WSJ | Reuters.com
US court invalidates key TEVA drug patent
Teva in Talks to Buy Allergan's Generic-Drug Unit - WSJ
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
Teva, Viatris win U.S. appeal in patent fight over Parkinson's drug | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
TEVA.TA - | Stock Price & Latest News | Reuters
Teva Pharmaceutical | PBS NewsHour
AstraZeneca Slumps on Report CEO Is Heading to Teva
Teva divesting $1 billion in assets to clear Allergan deal | Reuters.com
Teva Pharm bets on neurology drugs for growth as Q1 profit misses | Reuters
TEVA.N - | Stock Price & Latest News | Reuters
Teva and Eli Lilly scrap over migraine drug rights — MedWatch
Florida reaches $878 million opioid settlements with CVS, Teva, others | Reuters
Teva to pay up to $4.2 billion in U.S. to settle opioid claims | Reuters
GSK's $235 million verdict revived against Teva, again | Reuters
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
Teva CEO Exits Amid Crisis of Confidence at Drugmaker
Walgreens, Teva accused of fueling opioid addiction in quest for new markets | Reuters
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva to pay $523m. to New York as it looks to move past opioid lawsuits - The Jerusalem Post
Biden admin urges Supreme Court to hear 'skinny labels' case between Teva, GSK | Reuters
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
/cloudfront-us-east-2.images.arcpublishing.com/reuters/MH2PVUNNZRPNDLH3JJFMAIF3GE.jpg "Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters")
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva CEO Erez Vigodman to Step Down - WSJ
Teva Pharmaceutical CFO to step down: media | Reuters.com
